Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


24.09.2018

1 Acta Pharm
1 Adv Ther
1 Am Soc Clin Oncol Educ Book
1 Ann Clin Lab Sci
1 BMJ Case Rep
1 Cancer Radiother
1 Cell Physiol Biochem
1 Clin Cancer Res
1 Dis Markers
1 Eur Rev Med Pharmacol Sci
4 Eur Urol
1 Gene
1 In Vivo
2 Int J Mol Sci
1 Int J Surg Pathol
1 Int Urogynecol J
1 Iran J Kidney Dis
1 J Cell Biochem
2 J Cell Physiol
1 J Hum Genet
1 J Magn Reson Imaging
1 J Urol
1 Nat Commun
1 Oncoimmunology
2 Oncol Rep
2 Oncotarget
1 Surg Oncol
2 Urol Int
1 Urology
4 World J Urol


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Pharm

  1. YANG J, Ren Y, Lou ZG, Wan X, et al
    Paeoniflorin inhibits the growth of bladder carcinoma via deactivation of STAT3.
    Acta Pharm. 2018;68:211-222.
    PubMed     Text format     Abstract available


    Adv Ther

  2. NICKLAS AP, Kramer MW, Serth J, Hennenlotter J, et al
    Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC).
    Adv Ther. 2018 Sep 19. pii: 10.1007/s12325-018-0789.
    PubMed     Text format     Abstract available


    Am Soc Clin Oncol Educ Book

  3. ARAGON-CHING JB, Werntz RP, Zietman AL, Steinberg GD, et al
    Multidisciplinary Management of Muscle-Invasive Bladder Cancer: Current Challenges and Future Directions.
    Am Soc Clin Oncol Educ Book. 2018;:307-318.
    PubMed     Text format     Abstract available


    Ann Clin Lab Sci

  4. CHEN XF, Yeong J, Chang KTE, Lim AST, et al
    TFE3-Expressing Epithelioid Rich Perivascular Epithelioid Cell Neoplasm (PEComa) of the Bladder with Unusual Benign Course.
    Ann Clin Lab Sci. 2018;48:110-115.
    PubMed     Text format     Abstract available


    BMJ Case Rep

  5. AGGARWAL A, Singh V, Pandey S, Sinha RJ, et al
    Embryonal rhabdomyosarcoma of urinary bladder in an adult patient: an unusual manifestation.
    BMJ Case Rep. 2018;2018.
    PubMed     Text format     Abstract available


    Cancer Radiother

  6. SAFINI F, Jouhadi H, Marnissi F, Bouchbika Z, et al
    [Small cell neuroendocrine carcinoma of the bladder: Report of five cases and a review of the literature].
    Cancer Radiother. 2018;22:417-422.
    PubMed     Text format     Abstract available


    Cell Physiol Biochem

  7. CHEN X, Jia C, Jia C, Jin X, et al
    MicroRNA-374a Inhibits Aggressive Tumor Biological Behavior in Bladder Carcinoma by Suppressing Wnt/beta-Catenin Signaling.
    Cell Physiol Biochem. 2018;48:815-826.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  8. SEILER R, Gibb EA, Wang NQ, Oo HZ, et al
    Divergent biological response to neoadjuvant chemotherapy in muscle-invasive bladder cancer.
    Clin Cancer Res. 2018 Sep 17. pii: 1078-0432.CCR-18-1106.
    PubMed     Text format     Abstract available


    Dis Markers

  9. REIS H, Krafft U, Niedworok C, Modos O, et al
    Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.
    Dis Markers. 2018;2018:7308168.
    PubMed     Text format     Abstract available


    Eur Rev Med Pharmacol Sci

  10. WANG FH, Ma XJ, Xu D, Luo J, et al
    UPK1B promotes the invasion and metastasis of bladder cancer via regulating the Wnt/beta-catenin pathway.
    Eur Rev Med Pharmacol Sci. 2018;22:5471-5480.
    PubMed     Text format     Abstract available


    Eur Urol

  11. WILSON SS, Crawford ED
    Fewer Recurrences with Immediate versus Delayed Intravesical Mitomycin C: A Prospective Randomized European Trial.
    Eur Urol. 2018;73:233-235.
    PubMed     Text format    

  12. NECCHI A, Anichini A, Sonpavde G
    Of Chemoimmunotherapy Sequences and Delayed Disease-modifying Activity in Advanced Urothelial Carcinoma: Vetus Fit Novum.
    Eur Urol. 2018;73:153-155.
    PubMed     Text format    

  13. DYRSKJOT L
    Molecular Subtypes of Bladder Cancer: Academic Exercise or Clinical Relevance?
    Eur Urol. 2018 Sep 17. pii: S0302-2838(18)30656.
    PubMed     Text format    

  14. GARG H, Nayak B, Singh P
    Re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and Hi
    Eur Urol. 2018 Sep 17. pii: S0302-2838(18)30648.
    PubMed     Text format    


    Gene

  15. WANG HF, Wu JH, Gai JW, Yang SQ, et al
    MAN1B1 is associated with poor prognosis and modulates proliferation and apoptosis in bladder cancer.
    Gene. 2018;679:314-319.
    PubMed     Text format     Abstract available


    In Vivo

  16. RADES D, Dziggel L, Manig L, Janssen S, et al
    Predicting Survival After Whole-brain Irradiation for Cerebral Metastases in Patients with Cancer of the Bladder.
    In Vivo. 2018;32:633-636.
    PubMed     Text format     Abstract available


    Int J Mol Sci

  17. LIU YR, Ortiz-Bonilla CJ, Lee YF
    Extracellular Vesicles in Bladder Cancer: Biomarkers and Beyond.
    Int J Mol Sci. 2018;19.
    PubMed     Text format     Abstract available

  18. KOGA F, Takemura K, Fukushima H
    Biomarkers for Predicting Clinical Outcomes of Chemoradiation-Based Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer.
    Int J Mol Sci. 2018;19.
    PubMed     Text format     Abstract available


    Int J Surg Pathol

  19. LEE C, Kim B, Song B, Park JH, et al
    Clinicopathologic Features of Benign Neurogenic Tumor of Urinary Bladder.
    Int J Surg Pathol. 2018;26:221-228.
    PubMed     Text format     Abstract available


    Int Urogynecol J

  20. ZACHOVAL R, Dukatova K, Svabik K
    Vaginal ultrasound for imaging of a urinary bladder mass and treatment of a large leiomyoma of the urinary bladder in pregnancy.
    Int Urogynecol J. 2018;29:601-602.
    PubMed     Text format    


    Iran J Kidney Dis

  21. SUREKA B, Jain V, Jain S, Rastogi A, et al
    Cystitis Cystica Glandularis: Radiological Imitator of Urothelial Carcinoma.
    Iran J Kidney Dis. 2018;12:10.
    PubMed     Text format    


    J Cell Biochem

  22. ZHAO H, Bo Q, Wang W, Wang R, et al
    CCL17-CCR4 axis promotes metastasis via ERK/MMP13 pathway in bladder cancer.
    J Cell Biochem. 2018 Sep 19. doi: 10.1002/jcb.27494.
    PubMed     Text format     Abstract available


    J Cell Physiol

  23. FANG C, He W, Xu T, Dai J, et al
    Upregulation of lncRNA DGCR5 correlates with better prognosis and inhibits bladder cancer progression via transcriptionally facilitating P21 expression.
    J Cell Physiol. 2018 Sep 21. doi: 10.1002/jcp.27356.
    PubMed     Text format     Abstract available

  24. TAO T, Su Q, Xu S, Deng J, et al
    Downregulation of PKM2 decreases FASN expression in bladder cancer cells through AKT/mTOR/SREBP-1c axis.
    J Cell Physiol. 2018 Sep 17. doi: 10.1002/jcp.27129.
    PubMed     Text format     Abstract available


    J Hum Genet

  25. ARAI T, Fuse M, Goto Y, Kaga K, et al
    Molecular pathogenesis of interstitial cystitis based on microRNA expression signature: miR-320 family-regulated molecular pathways and targets.
    J Hum Genet. 2018;63:543-554.
    PubMed     Text format     Abstract available


    J Magn Reson Imaging

  26. VAN DER POL CB, Chung A, Lim C, Gandhi N, et al
    Update on multiparametric MRI of urinary bladder cancer.
    J Magn Reson Imaging. 2018 Sep 17. doi: 10.1002/jmri.26294.
    PubMed     Text format     Abstract available


    J Urol

  27. CHANG SS
    Re: Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C versus bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer.
    J Urol. 2018;200:696-697.
    PubMed     Text format    


    Nat Commun

  28. CHEN C, He W, Huang J, Wang B, et al
    LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment.
    Nat Commun. 2018;9:3826.
    PubMed     Text format     Abstract available


    Oncoimmunology

  29. POCH M, Hall M, Joerger A, Kodumudi K, et al
    Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancer.
    Oncoimmunology. 2018;7:e1476816.
    PubMed     Text format     Abstract available


    Oncol Rep

  30. LEBRUN L, Milowich D, Le Mercier M, Allard J, et al
    UCA1 overexpression is associated with less aggressive subtypes of bladder cancer.
    Oncol Rep. 2018;40:2497-2506.
    PubMed     Text format     Abstract available

  31. LIU CP, Zhang JH, Zheng SC, Liu J, et al
    A novel clinical multidimensional transcriptome signature predicts prognosis in bladder cancer.
    Oncol Rep. 2018;40:2826-2835.
    PubMed     Text format     Abstract available


    Oncotarget

  32. PRINCE T, Ackerman A, Cavanaugh A, Schreiter B, et al
    Dual targeting of HSP70 does not induce the heat shock response and synergistically reduces cell viability in muscle invasive bladder cancer.
    Oncotarget. 2018;9:32702-32717.
    PubMed     Text format     Abstract available

  33. DESGRANDCHAMPS F, LeMaoult J, Goujon A, Riviere A, et al
    Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG's receptor ILT2 on peripheral CD8(+) T cells.
    Oncotarget. 2018;9:33160-33169.
    PubMed     Text format     Abstract available


    Surg Oncol

  34. NUTT M, Scaief S, Dynda D, Alanee S, et al
    Ileus and small bowel obstruction after radical cystectomy for bladder cancer: Analysis from the Nationwide Inpatient Sample.
    Surg Oncol. 2018;27:341-345.
    PubMed     Text format     Abstract available


    Urol Int

  35. KRAJEWSKI W, Matuszewski M, Poletajew S, Grzegrzolka J, et al
    Are There Differences in Toxicity and Efficacy between Various Bacillus Calmette-Guerin Strains in Bladder Cancer Patients? Analysis of 844 Patients.
    Urol Int. 2018 Sep 18:1-8. doi: 10.1159/000492722.
    PubMed     Text format     Abstract available

  36. VETTERLEIN MW, Gild P, Marks P, Roschinski J, et al
    Evaluating Guideline Adherence for T1 Bladder Cancer Treatment and Surveillance: A Retrospective German Multicenter Observation.
    Urol Int. 2018 Sep 20:1-8. doi: 10.1159/000493369.
    PubMed     Text format     Abstract available


    Urology

  37. KHANNA A, Yerram N, Zhu H, Kim S, et al
    "Utilization of BCG for Non-Muscle Invasive Bladder Cancer in an Era of BCG Supply Shortages".
    Urology. 2018 Sep 13. pii: S0090-4295(18)30951.
    PubMed     Text format     Abstract available


    World J Urol

  38. FABA OR, Tyson MD, Artibani W, Bochner BH, et al
    Update of the ICUD-SIU International Consultation on Bladder Cancer 2018: urinary diversion.
    World J Urol. 2018 Sep 20. pii: 10.1007/s00345-018-2484.
    PubMed     Text format     Abstract available

  39. MITIN T, Choudhury A
    The role of biomarkers in bladder preservation management of muscle-invasive bladder cancer.
    World J Urol. 2018 Sep 14. pii: 10.1007/s00345-018-2480.
    PubMed     Text format     Abstract available

  40. COMPERAT E, Babjuk M, Algaba F, Amin M, et al
    SIU-ICUD on bladder cancer: pathology.
    World J Urol. 2018 Sep 14. pii: 10.1007/s00345-018-2466.
    PubMed     Text format     Abstract available

  41. MERSEBURGER AS, Apolo AB, Chowdhury S, Hahn NM, et al
    SIU-ICUD recommendations on bladder cancer: systemic therapy for metastatic bladder cancer.
    World J Urol. 2018 Sep 20. pii: 10.1007/s00345-018-2486.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: